Please assess the completion status of the following clinical trial:

Trial Title: The Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 6.0

Eligibility Criteria:
Inclusion Criteria:~* Participants with macular edema (swelling of the central part of the retina) associated with central retinal vein occlusion (CRVO) and branch retinal vein occlusion (BRVO).~* Individuals, 18 years of age or older, willing to provide consent may be eligible for the SCORE Study.~Exclusion Criteria: refer to SCORE Study website at https://web.emmes.com/study/score/ for listing.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- CRVO Observation (Type: ACTIVE_COMPARATOR): None
- CRVO 1 mg dose triamcinolone acetonide (Type: ACTIVE_COMPARATOR): None
- CRVO 4 mg dose triamcinolone acetonide (Type: ACTIVE_COMPARATOR): None
- BRVO standard care (Type: ACTIVE_COMPARATOR): None
- BRVO 1 mg dose triamcinolone acetonide (Type: ACTIVE_COMPARATOR): None
- BRVO 4 mg dose triamcinolone acetonide (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).